Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,195

The DOI matches its Crossref record.

Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage

Allen, George S., Ahn, Hyo S., Preziosi, Thomas J., Battye, Roy, Boone, Stephen C., Chou, Shelley N., Kelly, David L., Weir, Bryce K., Crabbe, Ruth A., Lavik, Paula J., Rosenbloom, Shelley B., Dorsey, Frank C., Ingram, Charles R., Mellits, David E., Bertsch, Linda A., Boisvert, Donald P. J., Hundley, Mary B., Johnson, Rayetta K., Strom, Jo A., Transou, Carole R.·1983·New England Journal of Medicine

Abstract

We enrolled 125 neurologically normal patients with intracranial aneurysms in a multi-institution, prospective, double-blind, randomized, placebo-controlled trial within 96 hours of their subarachnoid hemorrhage, to determine whether treatment with the calcium blocker nimodipine would prevent or reduce the severity of ischemic neurologic deficits from arterial spasm. A deficit from cerebral arterial spasm that persisted and was severe or caused death by the end of the 21-day treatment period occurred in 8 of 60 patients given placebo and in 1 of 56 given nimodipine (P = 0.03, Fisher's exact test). Analysis of the amount of basal subarachnoid blood on pre-entry CAT scans in patients with deficits from spasm showed that an increase in subarachnoid blood was not associated with a worse neurologic outcome among patients who received nimodipine, unlike the situation in patients given a placebo. There were no side effects from nimodipine. We conclude that nimodipine should be given to patients who are neurologically normal after subarachnoid hemorrhage in order to reduce the occurrence of severe neurologic deficits due to cerebral arterial spasm.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm198303173081103

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 1,195

Metadata

Authors
Allen, G. S., Ahn, H. S., Preziosi, T. J., Battye, R., Boone, S. C., Chou, S. N., Kelly, D. L., Weir, B. K., Crabbe, R. A., Lavik, P. J., Rosenbloom, S. B., Dorsey, F. C., Ingram, C. R., Mellits, D. E., Bertsch, L. A., Boisvert, D. P. J., Hundley, M. B., Johnson, R. K., Strom, J. A., & Transou, C. R.
Venue
New England Journal of Medicine
Published
1983-03-17
Volume
308
Issue
11
Pages
619-624
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2317146405
Cited by
1,195
References
0
FWCI
48.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage. https://app.cochat.ai/papers/10.1056/nejm198303173081103
The paper
Allen, G. S., Ahn, H. S., Preziosi, T. J., Battye, R., Boone, S. C., Chou, S. N., Kelly, D. L., Weir, B. K., Crabbe, R. A., Lavik, P. J., Rosenbloom, S. B., Dorsey, F. C., Ingram, C. R., Mellits, D. E., Bertsch, L. A., Boisvert, D. P. J., Hundley, M. B., Johnson, R. K., Strom, J. A., & Transou, C. R. (1983). Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage. New England Journal of Medicine. https://doi.org/10.1056/nejm198303173081103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.